Research
Dr. Walther leads a multi-dimensional research project aimed at developing a synthetic lung surfactant to treat breathing problems in preterm infants with surfactant-deficiency and lung immaturity (respiratory distress syndrome, RDS) and in children and adults with surfactant insufficiency caused by viral pneumonia or chemical lung injury (acute respiratory distress syndrome, ARDS).
His research is an essential element of the rescue treatment for infants, children and adults in respiratory distress. Dr. Walther’s lab seeks to design, synthesize, and bring effective lung surfactant peptides, modeled after the sequence of human surfactant proteins B and C (SP-B and SP-C) to clinical care. Additionally, he is working with the Gates Foundation towards developing an advanced lung surfactant preparation for aerosol delivery that would eliminate the need for tracheal intubation.
Biography
Dr. Frans Walther earned his medical degree from Leiden University (1972) and his PhD from Maastricht University (1982), both in the Netherlands.
Publications
Recent and significant publication(s) of his include: